Table 2.
Association between the miR-944 expression levels and clinicopathological characteristics of patients with cervical cancer
| Features | No. (%) | miR-944 expression | P | |
|---|---|---|---|---|
| (n = 66) | Low, n (%) | High, n (%) | ||
| No. of patients | 66 | 41 (62.1) | 25 (37.9) | |
| Age | 0.815 | |||
| < 45 years | 20 | 12 (60.0) | 8 (40.0) | |
| ≥ 45 years | 46 | 29 (63.0) | 17 (37.0) | |
| Histological type | 0.174 | |||
| ADC | 7 | 6 (85.7) | 1 (12.9) | |
| SCC | 59 | 35 (59.3) | 24 (40.7) | |
| Tumor size | 0.026 | |||
| < 4 cm | 30 | 23 (76.7) | 7 (23.3) | |
| ≥ 4 cm | 36 | 18 (50.0) | 18 (50.0) | |
| FIGO stage | 0.042 | |||
| IA-IIA | 29 | 22 (75.9) | 7 (24.1) | |
| IIB-IVB | 37 | 19 (51.4) | 18 (48.6) | |
| Lymph node metastasis | 0.030 | |||
| No | 35 | 26 (74.3) | 9 (25.7) | |
| Yes | 31 | 15 (48.4) | 16 (51.6) | |
Abbreviation; FIGO International Federation of Gynecology; P, Chi-square p-value